^
+ Follow DR. MOSES MASSAQUOI Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1362674
                    [Title] => US official warns Ebola outbreak will get worse
                    [Summary] => 

A third top doctor has died from Ebola in Sierra Leone, a government official said yesterday, as a leading American health official warned that the outbreak sweeping West Africa would get worse before it gets better.

[DatePublished] => 2014-08-28 05:18:44 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1236823 [AuthorName] => Clarence Roy-Macaulay and Jonathan Paye-Layleh [SectionName] => World [SectionUrl] => world [URL] => ) [1] => Array ( [ArticleID] => 1357886 [Title] => Liberia gets Ebola drug; ponders who should get it [Summary] =>

Liberian officials faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.

[DatePublished] => 2014-08-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413083 [AuthorName] => Jonathan Paye-Layleh and Sarah DiLorenzo [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
DR. MOSES MASSAQUOI
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1362674
                    [Title] => US official warns Ebola outbreak will get worse
                    [Summary] => 

A third top doctor has died from Ebola in Sierra Leone, a government official said yesterday, as a leading American health official warned that the outbreak sweeping West Africa would get worse before it gets better.

[DatePublished] => 2014-08-28 05:18:44 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1236823 [AuthorName] => Clarence Roy-Macaulay and Jonathan Paye-Layleh [SectionName] => World [SectionUrl] => world [URL] => ) [1] => Array ( [ArticleID] => 1357886 [Title] => Liberia gets Ebola drug; ponders who should get it [Summary] =>

Liberian officials faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.

[DatePublished] => 2014-08-15 01:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1413083 [AuthorName] => Jonathan Paye-Layleh and Sarah DiLorenzo [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with